Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
companion diagnostics
MedTech
Agilent, Incyte ink hematology, oncology companion testing deal
To better match its targeted therapeutics to the patients who will benefit most, Incyte has turned to Agilent to develop companion diagnostics.
Andrea Park
Jan 30, 2024 12:28pm
Agilent shuts down its Resolution cancer diagnostic business
Aug 22, 2023 10:20am
Tempus clocks FDA approval for 648-gene cancer test
May 8, 2023 8:05am
FDA looks to bypass cancer drugs' companion diagnostics: Pazdur
Nov 18, 2022 9:17am
Qiagen to develop companion diagnostic for Parkinson's drug
Sep 16, 2022 11:53am
Novartis tasks Foundation with companion diagnostic development
Oct 17, 2018 10:28am